{"id":"11bac76d-77fc-4bf0-9965-0f1a4735a1f8","kind":"companies","code":"UB-C1859","name":"Genesis Therapeutics","nameBasis":"source-english","summary":"Genesis Therapeutics is a company headquartered in Burlingame, United States, founded in 2019.","description":"","country":"United States","category":null,"originalName":"Genesis Therapeutics","eventDate":null,"website":"https://www.genesistx.ai/","sourceUpdatedAt":"2026-10-03T00:00:00.000Z","englishUpdatedAt":"2026-10-15T17:08:28.071Z","reviewedAt":"2026-10-15T17:08:28.071Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"38e554b455520a661f0669dafdc3ce2555daf37321f6de56250e8efe4c0d39b7","companyId":null,"foundedYear":2019,"logoUrl":null,"originalText":"","sources":[],"related":[{"id":"974ece3d-a608-4bfc-bd0b-621e8071efc3","kind":"people","code":"UB-P554","name":"Evan Feinberg","nameBasis":"original-brand","summary":"Genesis Therapeutics co-founder and CEO, with a biophysics doctorate from Stanford. Founded the AI drug discovery company in 2019 and developed its GEMS platform.","description":"Foreign national.","country":null,"category":null,"originalName":"Evan Feinberg","eventDate":null,"website":"https://www.linkedin.com/in/evan-feinberg-41b445262/","sourceUpdatedAt":"2026-10-09T09:04:26.512Z","englishUpdatedAt":"2026-10-15T22:06:44.571Z","reviewedAt":"2026-10-15T22:06:44.571Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"ed58beca40f1694a73bdfbf42e2e2444ce9733df881263872e0c0b8b463a7152","companyId":"11bac76d-77fc-4bf0-9965-0f1a4735a1f8","foundedYear":null,"logoUrl":null,"path":"/people/evan-feinberg"},{"id":"110929b7-a50e-4b8e-a034-6585e37b12d9","kind":"news","code":"110929b7-a50e-4b8e-a034-6585e37b12d9","name":"Genesis Therapeutics completes Series C financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"Genesis Therapeutics完成C轮融资","eventDate":"2024-11-14T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T10:58:12.611Z","englishUpdatedAt":"2026-10-15T17:19:59.245Z","reviewedAt":"2026-10-15T17:19:59.245Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"0f6ccb44d2eb218186f29ca2c7e78f9b347c0f3f4ab96057595b4a4ebd1d89b8","companyId":"11bac76d-77fc-4bf0-9965-0f1a4735a1f8","foundedYear":null,"logoUrl":null,"path":"/news/110929b7-a50e-4b8e-a034-6585e37b12d9"},{"id":"bb3a0968-c147-4064-86ac-f87a6b2c3336","kind":"institutions","code":"UB-I084","name":"NVIDIA","nameBasis":"original-brand","summary":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","description":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","country":null,"category":null,"originalName":"NVIDIA","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.514Z","englishUpdatedAt":"2026-10-15T21:37:02.777Z","reviewedAt":"2026-10-15T21:37:02.777Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"8a62c3d17681228b0f2100d52b9d441c8cbf7cd76ff11e3f9d0dc9bf9d6cb200","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nvidia"}],"finance":{"funding":{"metric":"funding","count":1,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":1,"records":[{"id":"110929b7-a50e-4b8e-a034-6585e37b12d9","date":"2024-11-14T00:00:00.000Z","round":"Series C","amountText":"未披露","estimateUsd":null,"estimateLabel":"Undisclosed","estimateNote":null,"investors":"Nvidia GPU Ventures","institutions":[{"id":"bb3a0968-c147-4064-86ac-f87a6b2c3336","kind":"institutions","code":"UB-I084","name":"NVIDIA","nameBasis":"original-brand","summary":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","description":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","country":null,"category":null,"originalName":"NVIDIA","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.514Z","englishUpdatedAt":"2026-10-15T21:37:02.777Z","reviewedAt":"2026-10-15T21:37:02.777Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"8a62c3d17681228b0f2100d52b9d441c8cbf7cd76ff11e3f9d0dc9bf9d6cb200","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nvidia"}],"newsUrl":null,"evidence":{"headline":"Genesis Therapeutics completes Series C financing","brief":null,"basis":null,"newsPath":"/news/110929b7-a50e-4b8e-a034-6585e37b12d9","sourceCount":0}}],"totalRaised":null},"valuation":{"metric":"valuation","count":1,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":1,"records":[{"id":"110929b7-a50e-4b8e-a034-6585e37b12d9","date":"2024-11-14T00:00:00.000Z","round":"Series C","amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":"Nvidia GPU Ventures","institutions":[{"id":"bb3a0968-c147-4064-86ac-f87a6b2c3336","kind":"institutions","code":"UB-I084","name":"NVIDIA","nameBasis":"original-brand","summary":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","description":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","country":null,"category":null,"originalName":"NVIDIA","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.514Z","englishUpdatedAt":"2026-10-15T21:37:02.777Z","reviewedAt":"2026-10-15T21:37:02.777Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"8a62c3d17681228b0f2100d52b9d441c8cbf7cd76ff11e3f9d0dc9bf9d6cb200","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nvidia"}],"newsUrl":null,"evidence":{"headline":"Genesis Therapeutics completes Series C financing","brief":null,"basis":null,"newsPath":"/news/110929b7-a50e-4b8e-a034-6585e37b12d9","sourceCount":0}}]},"revenue":{"metric":"revenue","count":0,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[]}},"events":[{"id":"110929b7-a50e-4b8e-a034-6585e37b12d9","kind":"funding","eventDate":"2024-11-14T00:00:00.000Z","revenueDate":null,"round":"C轮","amountText":"未披露","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":null,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"investors":"Nvidia GPU Ventures","newsUrl":null,"newsTypes":["融资"],"institutions":[{"id":"bb3a0968-c147-4064-86ac-f87a6b2c3336","kind":"institutions","code":"UB-I084","name":"NVIDIA","nameBasis":"original-brand","summary":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","description":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","country":null,"category":null,"originalName":"NVIDIA","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.514Z","englishUpdatedAt":"2026-10-15T21:37:02.777Z","reviewedAt":"2026-10-15T21:37:02.777Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"8a62c3d17681228b0f2100d52b9d441c8cbf7cd76ff11e3f9d0dc9bf9d6cb200","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nvidia"}],"roundName":"Series C","amountLabel":"Undisclosed","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null}],"team":[{"id":"974ece3d-a608-4bfc-bd0b-621e8071efc3","kind":"people","code":"UB-P554","name":"Evan Feinberg","nameBasis":"original-brand","summary":"Genesis Therapeutics co-founder and CEO, with a biophysics doctorate from Stanford. Founded the AI drug discovery company in 2019 and developed its GEMS platform.","description":"Foreign national.","country":null,"category":null,"originalName":"Evan Feinberg","eventDate":null,"website":"https://www.linkedin.com/in/evan-feinberg-41b445262/","sourceUpdatedAt":"2026-10-09T09:04:26.512Z","englishUpdatedAt":"2026-10-15T22:06:44.571Z","reviewedAt":"2026-10-15T22:06:44.571Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"ed58beca40f1694a73bdfbf42e2e2444ce9733df881263872e0c0b8b463a7152","companyId":"11bac76d-77fc-4bf0-9965-0f1a4735a1f8","foundedYear":null,"logoUrl":null,"path":"/people/evan-feinberg"}],"productsRelated":[],"investors":[{"id":"bb3a0968-c147-4064-86ac-f87a6b2c3336","kind":"institutions","code":"UB-I084","name":"NVIDIA","nameBasis":"original-brand","summary":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","description":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","country":null,"category":null,"originalName":"NVIDIA","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.514Z","englishUpdatedAt":"2026-10-15T21:37:02.777Z","reviewedAt":"2026-10-15T21:37:02.777Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"8a62c3d17681228b0f2100d52b9d441c8cbf7cd76ff11e3f9d0dc9bf9d6cb200","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nvidia"}],"path":"/companies/genesis-therapeutics","structured":{"city":"Burlingame","country":"United States","location":null,"role":null,"category":null,"company":null},"definition":"Genesis Therapeutics is a company headquartered in Burlingame, United States, founded in 2019.","summaryBasis":"generated","thin":false,"canonical":"https://uniquebase.ai/companies/genesis-therapeutics"}